Venmax Drugs and Pharmaceuticals Limited (BOM:531015)
12.36
-2.66 (-17.71%)
At close: Nov 16, 2026
| Market Cap | 179.02M +17.9% |
| Revenue (ttm) | 132.58M +333.2% |
| Net Income | 4.23M +22.7% |
| EPS | 0.25 -61.6% |
| Shares Out | 14.48M |
| PE Ratio | 48.49 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 167,897 |
| Open | 14.95 |
| Previous Close | 15.02 |
| Day's Range | 12.10 - 14.95 |
| 52-Week Range | 12.10 - 31.49 |
| Beta | -1.04 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 12, 2026 |